University Hospital of Toulouse
Toulouse, 31000, France
NCT Number: NCT04637126
Cardiac output monitoring is a key component for the diagnosis and management of critically ill patients. The two less invasive methods commonly used in intensive care are transthoracic echocardiography and transpulmonary thermodilution. The objective of this study is to compare accuracy and trending ability of CO measurement by TPTD and TTE in critically ill patients with sinus rhythm.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Toulouse, 31000, France
TTE is an easy noninvasive device now recommended as the first evaluation of the patient in circulatory failure but it present some limits due to poor echogenicity of patients, operator-dependent variability and cannot provide continuous hemodynamic data. TPTD is an invasive technique for CO monitoring recommended especially in shock not responsive to initial therapy.
Few studies have evaluated the level of agreement of each method (TTE and TPTD) with the reference method (pulmonary artery catheter) but they have never been compared between them with strong statistical analysis in particular trending ability.
It could be interesting to determine the level of concordance of these two methods of CO monitoring and trend ability by TPTD relative to TTE.
The investigators hypothesize that CO-TPTD are concordant with those performed by TTE.
Mechanically ventilated patients requiring hemodynamic assessment will be included. CO-TPTD will be measured via intermittent thermodilution. Blindly, a second investigator will use standard-view TTE to estimate CO-TTE as the product of stroke volume and the heart rate obtained during the measurement the blood flow velocity (using a Doppler technique) at the left ventricular outflow tract. A second measurement will be done with the two devices after a fluid challenge when patient requires it to compare trending ability.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cardiac output is measured for all patients with transpulmonary thermodilution TPTD and transthoracic echocardiography TTE according to the recommendations
Time frame: Day 0
bias between cardiac output measurement by transthoracic echocardiography and transpulmonary thermodilution
Time frame: Day 0
percentage error between cardiac output measurement by transthoracic echocardiography and transpulmonary thermodilution
Time frame: 15 minutes after inclusion
percentage error between the value of Cardiac Output measured with TTE and the value of Cardiac Output measured withTPTD after a fluid challenge.
Time frame: 15 minutes after inclusion
The ability of TPTD to track Cardiac Output as measured with TTE.
University Hospital, Toulouse
Other
Cardiac Output Measurement in Critically Ill Patient in Sinus Rhythm: a Comparison Between Transpulmonary Thermodilution and Transthoracic Echocardiography
Acronym: TPTD-TTE-SR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07102693
Brain Diseases, Cardiovascular Diseases
Dublin, Co. Dublin, Ireland
View Trial Details